Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, Manufactured for: Trigen Laboratories, LLC, Alpharetta, GA 30005, NDC 13811-708-10
Published July 10, 2024 · Recall initiated: June 17, 2024
Summary
FDA records drug Class II recall D-0579-2024, published July 10, 2024 and initiated June 17, 2024. Recalling firm: Trigen Laboratories; Status: Terminated; Reported quantity: 10,448 100-count bottles; Lot: Lot 230159M, Exp Date 2/28/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications.
What to do
Voluntary: Firm initiated · Letter
Get an email if METHYLPHENIDATE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- METHYLPHENIDATE HYDROCHLORIDE
- Manufacturer
- Trigen Laboratories
- Distributor
- Nationwide in the USA
- UPC
- 0313811706109
- Lot
- Lot 230159M, Exp Date 2/28/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALittle Moon Essentials, Clear Breeze Plus, Hand Sanitizer (Alcohol 65% v/v) Packaged as a) 2 FL OZ (60ML)July 10, 2024
- FDADodex Injectable (Cyanocobalamin Injection) USP, 1,000mcg/mL, 1mL multiple dose vial, Rx only, ManufacturedJuly 10, 2024
- FDAMethylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle, Manufactured by: OhmAugust 2, 2023
- FDAMethylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: RisingMarch 2, 2022
- FDAMethylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, TevaFebruary 19, 2020
- FDAMethylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, TevaFebruary 19, 2020
Questions about this recall
Was Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, Manufactured for: Trigen Laboratories, LLC, Alpharetta, GA 30005, NDC 13811-708-10 recalled?
Yes. FDA published recall D-0579-2024 on July 10, 2024. Reported hazard: Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: METHYLPHENIDATE HYDROCHLORIDE. UPC: 0313811706109.